Kinetics of Fluvoxamine and Digoxin in Subjects With Different MDR1 Genotypes
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
The investigators will compare plasma kinetics of two marker drugs in individuals with
different genetic variations in the MDR1-gene. The hypothesis is that one group will have
higher exposure than the other.